Vaxcyte, Inc. beat EPS estimates 0% of the time across 3 reported quarters (0 beats, 3 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.47 | $-1.97 | -34.0% | Miss |
| Q12026 FY2026 | $-1.86 | $-2.30 | -23.7% | Miss |
| Q42025 FY2025 | $-1.46 | $-1.80 | -23.3% | Miss |
Back to PCVX overview · PCVX holders · PCVX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.